Arun Jesudian, MD, details key findings from a study he recently presented at The Liver Meeting 2023.
Overt hepatic encephalopathy (OHE) is a serious neurological disorder that patients with cirrhosis are at risk of developing, and hospitalizations for OHE can be burdensome for patients and clinicians, according to Arun Jesudian, MD, director of Inpatient Liver Services at Weill Cornell Medicine in New York.
Dr Jesudian recently presented a study at the American Association for the Study of Liver Diseases’ annual scientific conference, The Liver Meeting 2023, titled "Systematic undercounting of overt hepatic encephalopathy hospitalizations identified by using hospital-administered medication data." The study investigated data on hospital-administered medications as an additional means to identify OHE cases and the cost implications of underestimating hospitalizations for the condition.
Dr Jesudian sat down with Patient Care Online to discuss the study in more detail, including the main findings and takeaways for primary care clinicians. The conversation follows in the video below.